|Assessment Process Complete
|Is indicated for the treatment of adults with locally advanced or metastatic non-squamous NSCLC after prior chemotherapy.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation Recommended
|Full submission received from Applicant
|NCPE assessment completed
|NCPE assessment outcome
|Reimbursement Not Recommended at the Submitted Price.
The HSE has approved reimbursement following confidential price negotiations September 2018